These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30642048)

  • 1. Content/Potency Assessment of Botulinum Neurotoxin Type-A by Validated Liquid Chromatography Methods and Bioassays.
    Xavier B; Perobelli RF; Walter ME; da Silva FS; Dalmora SL
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30642048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A.
    Gregory RW; Werner WE; Ruegg C
    J Pharmacol Toxicol Methods; 2014; 69(2):103-7. PubMed ID: 24333955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant human parathyroid hormone by CZE method and its correlation with in vitro bioassay and LC methods.
    Maldaner FP; Perobelli RF; Xavier B; Remuzzi GL; Walter ME; Dalmora SL
    Talanta; 2017 Jan; 162():567-573. PubMed ID: 27837872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of recombinant human parathyroid hormone: correlation of LC methods with bioassays.
    Stamm FP; Calegari GZ; de Freitas GW; Souto RB; Porto LP; Cardoso CD; Dalmora SL
    Analyst; 2013 Mar; 138(5):1419-26. PubMed ID: 23324983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-indicating capillary zone electrophoresis method for the assessment of recombinant human interleukin-11 and its correlation with reversed-phase liquid chromatography and biossay.
    Souto RB; Stamm FP; Schumacher JB; Cardoso CD; de Freitas GW; Perobelli RF; Dalmora SL
    Talanta; 2014 Jun; 123():179-85. PubMed ID: 24725881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin.
    Sesardic D; Leung T; Gaines Das R
    Biologicals; 2003 Dec; 31(4):265-76. PubMed ID: 14624797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Validation of the Equivalence of the Cell-Based Potency Assay Method with a Mouse LD
    Yang Y; Zhang H; Yuan L; Wang S; Ma X
    Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
    Szílagyi M; Rivera VR; Neal D; Merrill GA; Poli MA
    Toxicon; 2000 Mar; 38(3):381-9. PubMed ID: 10669027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avian eyelid assay, a new diagnostic method for detecting botulinum neurotoxin serotypes A, B and E.
    Wang J; Gao S; Zhang Q; Kang L; Liu Y
    Toxicon; 2007 Jun; 49(7):1019-25. PubMed ID: 17367833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of streptokinase by validated liquid chromatography methods and correlation with an in vitro bioassay.
    Cardoso CD; Perobelli RF; Xavier B; Maldaner FP; da Silva FS; Dalmora SL
    J Sep Sci; 2017 Jan; 40(2):407-414. PubMed ID: 27808464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations.
    Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Seagar M; El Far O
    Appl Microbiol Biotechnol; 2015 May; 99(10):4355-60. PubMed ID: 25672850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination.
    Pellett S; Tepp WH; Toth SI; Johnson EA
    J Pharmacol Toxicol Methods; 2010; 61(3):304-10. PubMed ID: 20100585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS; Pickett A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The botulinum neurotoxin LD50 test - problems and solutions.
    Bitz S
    ALTEX; 2010; 27(2):114-6. PubMed ID: 20686744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
    Bigalke H; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
    Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
    Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics.
    Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B
    Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid chemiluminescent slot blot immunoassay for the detection and quantification of Clostridium botulinum neurotoxin type E, in cultures.
    Cadieux B; Blanchfield B; Smith JP; Austin JW
    Int J Food Microbiol; 2005 May; 101(1):9-16. PubMed ID: 15878402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.